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Abstract: There is a high prevalence of drug use among psychiatric patients, favoring worse prognosis and situations of vulnerability. 
The aim of this study was to understand the perception and management of mental health professionals related to the use of drugs 
among people receiving psychiatric care. Semi-structured interviews were conducted with 16 professionals. Through thematic 
analysis, three categories were constructed: (1) Identification of drug use, performed with some difficulty through self-reports, 
collected by doctors and nursing assistants, being the essential link; (2) Actions taken to manage drug use situations, focusing 
on abstinence counseling and many referrals; (3) Presence of moral discourses in the care offered. The  team  reports  difficulties 
in  dealing  with  situations  of  drug  use  among patients, from identification to management. The different ways of dealing with 
consumption were related to how the professional understands the use of drugs.
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Uso de Drogas por Pessoas em Tratamento Psiquiátrico:  
Manejo e Percepção dos Profissionais
Resumo: Há alta prevalência de consumo de drogas entre pacientes psiquiátricos, favorecendo pior prognóstico e situações de 
vulnerabilidade. O objetivo deste estudo é compreender a percepção e o manejo de profissionais de saúde mental sobre o uso 
de drogas entre pessoas em tratamento psiquiátrico. Foram realizadas entrevistas semiestruturadas com 16 profissionais. Foram 
construídas três categorias a partir de análise temática: (1) Identificação do uso de drogas, realizada com certa dificuldade por meio 
de autorrelato colhido por médicos e auxiliares de enfermagem, destacando-se o vínculo como essencial; (2) Ações realizadas para 
manejar situações de uso de drogas, focadas na orientação para abstinência e resultando em muitos encaminhamentos; (3) Presença 
de discursos morais no cuidado oferecido. A equipe relata dificuldades para lidar com situações de consumo de drogas relatadas pelos 
pacientes, desde a identificação até o manejo. As diferentes formas de lidar com o consumo mostram-se relacionadas ao modo como 
o profissional de saúde mental compreende o uso de drogas.
Palavras-chave: pacientes psiquiátricos, droga (uso), profissionais da saúde
Uso de Drogas por Personas en Tratamiento Psiquiátrico:  
Percepción y Acompañamiento de los Profesionales
Resumen: Hay alta prevalencia de consumo de drogas entre pacientes psiquiátricos, favoreciendo peor pronóstico y situaciones de 
vulnerabilidad. El objetivo de este estudio es comprender la percepción y el manejo de profesionales de salud mental sobre el uso 
de drogas entre personas en tratamiento psiquiátrico. Se realizaron entrevistas semiestructuradas con 16 profesionales. Con análisis 
temático se construyeron tres categorías: (1) Identificación del uso de drogas, realizada con cierta dificultad por medio de autorrelato 
recogido por médicos y auxiliares de enfermería, destacándose el vínculo como esencial; (2) Acciones realizadas para manejar 
situaciones de uso de drogas, siendo éstas enfocadas en la orientación hacia abstinencia y ocurriendo muchos encaminamientos; 
(3) Presencia de los discursos morales en el cuidado ofrecido. El equipo relata dificultades para lidiar con situaciones de consumo 
de drogas entre los pacientes, desde la identificación hasta el manejo. Las diferentes formas de lidiar con el consumo se muestran 
relacionadas con el modo en que el profesional de salud mental comprende el uso de drogas.
Palabras clave: pacientes psiquiátricos, drogas (uso), profesionales de la salud
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The use of substances by people with psychiatric diagnoses 
is highlighted in the literature as becoming increasingly prevalent 
(Hamilton, 2010; Schlosser & Hoffer, 2012). A survey carried 
out among psychiatric inpatients found that 12% consumed 
alcohol and 28% used illicit drugs (Mordal et al., 2011). 
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A study conducted in two community mental health services 
identified that 13.6% of the participants presented problematic 
consumption of alcohol and 9% of illicit drugs (Corradi-
Webster & Gherardi-Donato, 2016).
Drug use can affect people with a psychiatric condition 
in several ways, and is related to increased symptoms 
(Nehlin, Fredriksson, & Jansson, 2012), homelessness, risk 
behaviors, crime, and a decrease adherence to medication. 
These factors can lead to a greater need for use of mental 
health services and psychiatric hospitalizations (Mordal et 
al., 2011; Ostacher et al., 2010). For Williamson, Johnson, 
Mullen and Wilson (2012) one of the factors causing the 
“revolving door” effect in mental health services is the use 
of drugs by people with psychiatric conditions.
Faced with this problem, the identification of drug use 
among users of mental health services is essential for the 
adequacy of treatment plans. However, this identification 
is still underestimated in the services (Corradi-Webster, 
Laprega, & Furtado, 2009) and among the reasons for this 
are the fear of patients being stigmatized by the team and the 
fear of admitting consumption of a drug considered illicit 
(Hamilton, 2010). For Corradi-Webster (2013) patients also 
fear that when addressing this issue they will be referred to 
specialized services in the treatment of problems related to 
drug use and lose the link with the mental health service 
in which they are being monitored. Vieira (2016) observed 
that mental health services tend to refer all individuals 
who use illicit drugs to specialized services, regardless of 
consumption pattern, impairing the link and the relationship 
of trust between drug user and professional, increasing cases 
of underreporting. The limited time available to professionals 
for the complete evaluation and diagnosis also seems to 
contribute to the non-identification (Corradi-Webster et 
al., 2009) or to the professional having difficulty correctly 
evaluating the consumption pattern and the impact of this 
on the individual, resorting to referral even in situations of 
sporadic and/or recreational use (Vieira, 2016). Szerman et 
al. (2014) suggest that mental health teams address this issue 
in an way that is integrated to the service procedures.
The literature has named “comorbidity” the situations 
in which one or more disorders are identified in the same 
individual. However, there is a diversity of understandings 
and a difficulty in defining what comorbidity is, impacting 
on identification and treatment (Morojele, Saban, & Seedat, 
2012). If it is understood as two independent conditions, 
with distinct clinical courses, a strict separation between 
mental health services and specialized services for the use of 
substances is justified (Schuckit, 2006). However, Krueger 
and Markon (2006) emphasize that a person who fulfills 
criteria for a specific mental disorder is more likely to meet 
criteria for another disorder, indicating that the different 
constructs named as mental disorders are correlated. For 
the authors, nosological categories would share the same 
susceptibilities, being only alternative manifestations. They 
suggest that treatment should focus on these susceptibilities 
and point out personality traits as aspects that would be 
common in different disorders.
Another explanatory model for comorbidity is that one 
clinical picture would influence the development of the other, 
as in situations in which drug use aims self-medication (Nehlin 
et al., 2012). Drug use would be a way to deal with some 
symptoms and also with side effects of psychotropic medications 
(Hamilton, 2010). A study with patients with schizophrenia that 
used marijuana identified that, despite an increase in positive 
symptoms, many continued to consume the substance because 
they considered it to help control auditory hallucinations as well 
as decrease anxiety and insomnia (Costain, 2008). The lack of 
space to talk about the effects and autonomous management 
of psychotropic drugs (Onocko-Campos et al., 2013) can also 
contribute to the individual seeking from the drug use a way of 
dealing with undesirable side effects.
One of the difficulties of the therapeutic approach in cases 
of substance use by people with psychiatric disorders is due to 
the existing division between services, hindering the diagnostic 
evaluations that investigating the presence of drug use in 
patients in mental health services, disrupting comprehensive 
care (Silva, Kolling, Carvalho, Cunha, & Kristensen, 2009). 
Services specialized in comorbidities are incipient and not 
always recommended, with the suggestion that mental health 
teams approach this issue in a way that is integrated to the 
service procedures (Szerman, et al., 2014). In addition, many 
people receiving psychiatric treatment and who consume drugs 
do not meet criteria for substance use disorders, because they 
use drugs in a recreational or sporadic way, and referral to 
specialized drug services is not justified (Vieira, 2016).
Hamilton (2010) highlights the need for action in the area 
that takes into account the patients’ point of view, helping 
them plan changes in their lifestyles, acquiring and improving 
social bonds, rather than just focusing on outcomes related to 
symptomatology. Corradi-Webster and Gherardi-Donato (2016) 
recommend that mental health services value psychosocial 
actions, seeking to investigate the patients’ social support 
network, their modes of socialization and financial needs, since 
the use of substances may be related to these issues.
Considering the high prevalence of drug use among psychiatric 
patients, the existing division in the care network between mental 
health services and services targeting drug users and the need to 
provide integral assistance, it is necessary to investigate how drug 
use situations are managed in mental health services, in order to 
identify fragilities that need to be remedied and resources that 
can be disseminated among services. Therefore, the aim of this 
study was to understand the perception and management by 
mental health professionals regarding the use of drugs among 
people receiving psychiatric treatment.
Method
A study with a qualitative, descriptive and experiential 
design, aiming to validate meanings, perspectives and 
practices in the constructed corpus, focusing and prioritizing 
the interpretations made by the participants, without using 
them as a basis for other theoretical interpretations (Braun 
& Clarke, 2014). 
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Participants
A total of 16 professionals participated in this study 
of a community mental health service in a medium-sized 
municipality in the state of São Paulo, Brazil. All the 
employees who were part of the morning team (07:00 to 
13:00) were invited to participate. This period was selected 
due to focusing most of the team and service activities. The 
inclusion criteria were: (a) to be part of the fixed team of the 
selected service, working at least once a week in the morning; 
(b) to have worked in the position for at least six months; and 
(c) to have contact at the service level with the service users. 
Regarding gender, seven men and nine women participated. 
Considering the professional category, three psychiatrists, 
one nurse, one pharmacist, three psychologists, a social 
worker, an occupational therapist, five nursing technicians 
nd an administrative technician participated.
Instruments
The instrument used was the semi-structured interview 
script, elaborated based on the objective of the study. This 
instrument allows the researcher to have a script with 
questions that need to be addressed, with a space for other 
topics to be brought by the interviewer, considering the words 
used, the orders of the questions and the deepening given to 
the theme adapted to the context and report of the patient 
(Braun & Clarke, 2014). In order to better understand the 
interviewee, the script was initially composed of questions 
about professional training and working time at the 
institution, followed by questions that sought to investigate 
how the professional understood drug use and the user. 
Afterwards, questions were focused on the theme studied, 
seeking to investigate how the professionals understood 
the use of drugs by people with psychiatric disorders, how 
these situations appeared and were managed in the service 
where they worked and how they felt they could contribute 
to dealing with these cases.
Procedure
Data collection. The study proposal was presented at 
the service team meeting and doubts about the intention and 
procedures of the study were answered. Professionals who 
fulfilled the inclusion criteria were individually invited to 
participate in the study and the interviews were scheduled 
individually. Fifteen participants chose to perform the interview 
in the service studied, in rooms used for the consultations, and 
only one of them preferred that it be performed in their private 
practice, due to the lack of time during their work in the 
service. The collection was carried out in the first half of 2014. 
All interviews were audio-taped and the corpus consisted of 
15 hours and 35 minutes of interviews, with the average time 
of each one being 57 minutes.
Data analysis. Thematic analysis was carried out 
according to Braun and Clarke (2006). The analysis was 
conducted in six phases: (1) Familiarization with the data 
through the complete transcription of interviews and readings; 
(2) Construction of initial codes, identifying statements that 
were relevant to the purpose of the study and codifying 
what they were about; (3) Construction of themes through 
the organization of the codes; (4) Review of the themes, 
seeking to investigate how these were related to the initial 
codes and data as a whole and production of thematic maps; 
(5) Definition and naming of themes; (6) Production of the 
final report through the selection of extracts that illustrated 
the topics and the discussion of the results considering the 
literature of the area. Steps 2, 3, 4 and 5 were performed 
separately by the two authors of this paper and the final 
results were negotiated between them.
Ethical Considerations
The project was approved by the Ethics 
Committee for Research with Human Subjects (CAAE 
20875913.6.0000.5407). All participants read and signed 
the consent form. Seeking to preserve the identities of the 
interviewees, in the transcription of the statements, all were 
treated as being of the masculine gender.
Results and Discussion
After analyzing the thematic content, the data were 
organized into three themes: Identification of drug use in 
service patients; Actions taken in the mental health service to 
deal with drug use situations; Presence of moral discourses 
in the care offered.
Identification of Drug Use in Patients in the Service
For the professionals, many patients seen in the mental 
health service consume drugs and they consider that this 
consumption produces numerous unfoldings in the treatment 
of these people, with the need for identification being urgent. 
In this theme. the resources and difficulties that were listed 
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Figure 1. Identification of drug use in service patients. 
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Despite the importance attributed to the identification of drug 
use, analysis of the corpus indicated that there is no protocol for its 
implementation. Several professionals mentioned the importance 
of this evaluation, either to provide more adequate care within the 
service, or to consider the referral of these patients for treatment 
in other services of the network. The identification of drug use 
is usually done from the user’s own report; however, this type 
of report does not seem to be so easily obtained. Participant P2 
pointed out that the patient does not talk about drug use at first, 
sometimes lying or omitting his/her consumption in their report to 
the team: “I actively ask, what is the frequency, what drug do you 
use, and even if they initially lie, in the end they end up talking”.
Although the survey has emerged as the main strategy of 
professionals to identify drug use, it has not proved to be a simple 
process to implement because of the stigma attached to the use of 
these substances. The literature recommends that the evaluation of 
drug use can be performed through clinical interview, standardized 
instruments or toxicological tests (Mordal et al., 2011; Nehlin et 
al., 2012). In the statement of P2 it was observed that more time 
spent on the evaluation can collaborate the report of the patient. 
However, professionals often do not have enough time to do an 
in-depth interview (Corradi-Webster et al., 2009). For this reason, 
Nehlin et al. (2012) argue that asking a single question about 
alcohol use would be more important than not addressing the 
issue at all. Another barrier found to collect the patient’s report 
refers to the difficulty of some professionals in asking questions 
related to drug use. The statement of P5 exemplifies this situation:
Sometimes yes (question about use), but not directly, 
because that offends, so I try to ask ‘And then, 
is there anything different?’ The person himself 
speaks ‘No, no, I do not use drugs, I do not use 
drugs anymore’. Sometimes I say, ‘Oh, is everything 
okay?’, ‘Did something different happen?’, ‘Did 
you do anything different?’ They say, ‘No, no, I’m 
not using drugs anymore’.
In this statement it can be noticed that the professional 
did not consider the evaluation of the use of drugs to be a 
health issue, since he worried about offending the patient 
when asking about the subject. He treated the issue as if it 
was something intimate, and thus the bond becomes essential 
for the conversation to take place. Therefore, it would require 
some time and also effort of the professional in constructing 
a favorable atmosphere for the report. 
Some professionals were listed as being in a privileged 
situation to collect the patient’s report. For the interviewees, 
the contact in the medical consultation would invite more 
confidential moments, because they are held in closed rooms and 
at scheduled times, in addition to a more directive posture of the 
medical professional, investigating several areas of the patient’s 
life. These factors could contribute to the identification, as 
described by P9: “And we may suspect or not, but independently, 
the person will undergo the evaluation of the doctor and the 
doctor identifies this quickly”.
The nursing team was also listed as important in this 
evaluation. These professionals meet with patients in structured 
therapeutic activities and also in the corridors, participate in 
lunch together, as well as perform shifts on weekends and in 
the afternoon and evening. This contact seems to enable a 
consistent link between professional and patient, establishing 
a relationship of care and trust, in order to obtain important 
information for the construction of the therapeutic project. 
Participant P9 emphasized that nursing auxiliaries would be 
better able to perceive and identify this use of drugs within 
the service: “auxiliaries are the ones who perceive the most, 
because they live with that person more, the coexistence is 
much more intense”. As this topic seems difficult to talk about, 
the bond would help the patient to feel more willing to report 
on consumption (Nehlin et al., 2012).
For Hamilton (2010) the nursing team plays a fundamental 
role in the detection of substance use in patients diagnosed with 
mental disorders and they should be alert to the signs. However, 
Vieira, Caldana and Corradi-Webster (2013) reported that, despite 
the physical proximity of nursing auxiliaries and patients favoring 
a deepening of the bond between them, there is still a great 
prejudice in relation to mental health service patients who use 
drugs, which could impair therapeutic actions. These professionals 
have experiences with mental health, however, working with 
people who also use drugs requires a change in their practices, 
which involves not only agreeing that old practices need to be 
reviewed, but also constructing new ones, something that cannot 
be done fast and linearly (Brousselle, Lamothe, Sylvain, Foro, 
& Perreault, 2010). 
Actions Performed in the Mental Health Service to Manage 
Drug Use Situations
In this theme the actions that are carried out in the service 
to manage the situations in which the drug use presents itself 
were organized. Figure 2 illustrates how the different actions 
reported are based on the professionals’ understanding about 
the reasons for drug use and also their views on what the 
treatment in mental health should be. 
Referral for 
hospitalization
Recreational use Drug use as a 
copingstrategy




















Figure 2. Actions taken in the service to handle situations of 
drug use.
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Practitioners consider the interaction between drug use 
and medicines to be dangerous and this argument is used 
to support the guideline that patients should entirely refrain 
from consuming other substances. This is observed in the 
statement of P5: 
Some medicines, most of them are like that, 
they suffer interaction with alcohol, in fact I 
think 90%,.. You will have the interactions and 
depending on the quantity, it can lead to coma… 
then it cannot happen at all.
For Onocko-Campos et al. (2013), although there are 
different care tools in the context of community mental health 
services, the central role attributed to medication makes 
regular use of the medicine synonymous with treatment, 
often leading to the understanding that if the patient does not 
use the medication as it has been prescribed he is resisting 
treatment and should not continue in the service. This helps 
to understand the difficulty of professionals dealing with 
situations in which patients also consume recreational drugs. 
If the medicine use is seen as central to the treatment and, as 
highlighted in P5’s statement, the medicine’s interaction with 
drugs is considered to always be very dangerous, it is difficult 
to think of ways to care for people who have psychiatric 
disorders and use drugs. The statement of P3 illustrates this 
difficulty: “The psychiatric patient, who makes use of drugs, 
there is no way to treat such a patient. You give him medicine 
and he continues using drugs. I mean, you’re potentialzing 
the drug, potentializing alcohol. There’s no way to handle it”. 
Since they do not see possibilities of treatment in the 
mental health service for people who are using any drug, 
the professionals focus on the importance of abstinence, as 
a criterion so that they can continue the service. Participant 
P9 addressed this question: “Ideally, he should not stay here, 
at least as long as he’s using it. Now, if he is in treatment, in 
abstinence, there it is okay”. The referral for hospitalization 
is understood as the solution to these situations, since 
this would be the therapeutic resource that would make it 
possible to keep the person away from drug use. This can be 
illustrated in the statement of P2: “and we have to keep the 
person hospitalized, and it is not three months, a year! It’s a 
fairly long hospital stay”.
Some possibilities of negotiation are proposed when 
they understand that the consumption of drugs is something 
recreational. For P5, even considering the use of medications 
as a synonym for treatment and being concerned about 
the interaction between these medicines and alcohol, 
it was necessary to negotiate with patients and provide 
harm reduction guidelines, thus ensuring continuity in the 
treatment. 
So now if you’re going to talk to a patient like 
E., she likes to drink a beer, she takes sertraline 
and clonazepam, what I told her was about using 
alcohol and clonazepam, which can be dangerous, 
but she cannot stop taking the medicine     . . 
Then she cannot be without the medicine and 
she used to stop taking the medicines, because 
she wants to drink a little, then talking to her 
and the amount she said she drinks, it does not 
interfere with her medications so much, so it is 
better that she take the medicines clonazepam 
and carbamazepine and at night if she wants a 
little beer okay, but only on Saturday, which was 
agreed. Its better to talk like that than to tell her 
that she cannot ever drink, if I said that, she’ll 
drop the treatment, she will not quit drinking the 
beer on Saturday night.
An attempt of negotiation between professional and 
patient can be observed in this statement. Even considering 
that abstinence would be more appropriate, the professional 
sought to investigate the habits of the patient and took them 
into account when providing the guidelines. Schlosser and 
Hoffer (2012) emphasize the importance of the team being 
aware that often the patient of mental health services who 
uses drugs will continue to consume them during psychiatric 
treatment, not basing their practices on the illusion of 
complete abstinence.
In some situations the professionals consider that the 
use of drugs appears as an attempt for self-medication of the 
individuals and observe how it develops rather than focusing 
a priori on the strategy of abstinence, as observed in the 
statement of P6. 
A schizophrenic patient I attended smoked 
marijuana and marijuana made him very calm, so 
marijuana worked for him as an anxiolytic. Then 
he smoked marijuana and became relaxed, less 
distressed, less aggressive, less irritated . . . And 
then? That’s nice? This is bad? Is that right? Is 
that wrong? Should he stop? Should he continue? 
I do not know, I honestly do not know. So I do 
not know if for this patient the use of marijuana is 
bad . . . It may be necessary, so I try to have this 
posture, of not having a lot of prior conceptions, 
of trying to look at it, is it not worth it in this case 
to continue using?
Anguish can be perceived in the statement of P6 in 
relation to how to deal with the situation. On the one hand, 
still inconclusively, the literature reports that there seems 
to be a possible association between marijuana use in 
adolescence and the development of schizophrenia (Proal, 
Fleming, Galvez-Buccollini, & DeLisi, 2014), and that this 
consumption may increase positive symptoms (Costain, 
2008). On the other hand, patients report improvement in 
symptoms when consuming marijuana (Costain, 2008). In 
the case reported, the professional interviewed chose not 
to focus on abstinence and to observe the development of 
the framework, understanding that even knowing the risks, 
he should respect the way the patient had chosen to deal 
with his/her suffering. Strategies focused on harm reduction 
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are still poorly disseminated to the population receiving 
treatment for mental disorders, since professionals focus on 
abstinence due to the interaction of drugs with medications 
and also for fear of worsening the clinical status. However, 
as many people continue to use drugs, these strategies also 
need to be developed in the area. In London, a booklet was 
published for practitioners and users, with guidelines on the 
use of marijuana by people with schizophrenia (Linnell & 
Holland, 2007). This included guidelines on the effects of 
the substance, possible interactions with medications and 
how the user can see whether the consumption has harmed 
him, as well as tips for situations where he realizes that the 
effects of consumption are undesirable. The benefit of these 
interventions is that they open space for dialogue, since 
the professional goes beyond the guidance that the patient 
should not use the drug.  
It was also observed that when there is an understanding 
of drug use as a strategy to confront unpleasant feelings 
and sensations, other therapeutic resources, in addition to 
abstinence guidelines, were mentioned. Participant P1 talked 
about the importance of helping the patient to develop better 
adapted confronting alternatives.
So I see people as defending themselves, using 
drugs they are trying to lessen the discomfort. 
I think that anyone who is using drugs needs a 
look at that need that is behind the drug. Can you 
organize this life so that you can sleep better? 
In this situation, it was observed that possibilities 
for dialogue are amplified and that the professional takes 
responsibility for the patient, helping him to think of other 
strategies to manage stress situations. 
Presence of Moral Discourses in Care
This topic discusses how moral discourses influence 
the positions taken by the professionals when faced with 
the use of drugs by users of mental health services. Figure 3 
graphically presents the unfolding results of this discourse.
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Figure 3. Presence of moral discourses in the care offered.
While the psychiatric disorder is understood as something 
that victimizes the individual, drug use is perceived as an 
option, making it difficult for the professional to empathize 
with the patient’s suffering. This can be seen in the statement 
of P14:
I’m totally against it. I think I have a very large 
defect, that I cannot view a psychiatric patient, 
who had an outbreak, has a problem, and who is 
sick by drug use in the same way. The chemically 
dependent patient. So I cannot have the same 
view, the patient that is having a crisis, I think he 
did not choose that, it happened, while the patient 
who is having a crisis due to drinking, or who 
became dependent on chemicals for some reason, 
he sought it out.
Vieira et al. (2013) interviewed nursing auxiliaries 
who had worked in a psychiatric hospital for many years 
and reported that they had recently received cases of 
comorbidity. They observed that they had many difficulties 
in accepting drug users as people who also needed care. 
The view of drug use as a moral problem differentiates the 
patient with comorbidities from the non-drug user. The user 
is called shameless and someone who does not deserve 
health care. For Goffman (1988) the stigma is like a mark 
that accompanies certain groups, signaling that they should 
be avoided or marginalized. Ronzani, Noto and Silveira 
(2014) point out that stigma related to the drug user is a 
factor that hinders access and care of these people in health 
services, since users end up being identified as dangerous 
or irresponsible. Furthermore, for the authors, the stigma 
produces feelings of de-motivation in health professionals 
and distances them from the patients.
Moral discourses constructing meanings about drug 
use were reported as being present in the professional 
training, together with the lack of formal spaces for scientific 
discussion on the theme. The statement of participant P2 
illustrates this situation:
I did not have chemical dependency training at my 
university. I see that it can be even a consequence 
of prejudice even though it was practically treated 
with disregard. You can understand that the 
bosses wanted to get rid of the patient who was 
dependent, and treated him as if he was a “thing”, 
“shameless” and did not deserve care and that the 
other patients deserved it more.
It can be noted that the position adopted faced with the 
moral discourses is to “want to get rid of them quickly” to 
give attention to other patients who would be more deserving 
of care. When the service identified the use of drugs, the 
professionals were quite emphatic in claiming that they 
perceived the prejudice on the part of their colleagues of the 
team, often not taking responsibility for the patient, seeking 
to refer him to other services, as mentioned by P6. 
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I think prejudice exists, when that person is 
identified as a user, people’s views tend to change 
about that person. In addition, I think there 
is often a tendency to throw the problem into 
another sphere: ‘Ah . . . is not it better to refer for 
hospitalization?’, ‘Ah . . . is it not better to refer to 
the drug service?
Personal and family experiences were also reported as 
influencing the posture adopted by the professionals. The 
use of drugs by relatives contributed to the professionals 
adopting the moral discourse (drug use as a personality 
problem and lack of will) to position themselves faced with 
this issue at work. The implication was the option of not 
getting involved in the care of people who used drugs and 
not talking about it with the patients. These constructions are 
always associated with statements of not being trained on the 
topic, as is illustrated in the statement of P7.
Due to having people in my family that abused 
drugs I always had a very great prejudice . . . 
and I did not have much scientific training on 
this, but something more personal that they 
had no goodwill, that they did not want to treat 
themselves, boredom. So I’ve always put that as a 
limit on my training, I never wanted to work with 
people who had any issues with abusive use.
Moral discourses constructing meanings about drug 
consumption as a character problem are very widespread 
and limit the work of professionals, since they work within 
the field of health and not morality. Pillon and Luis (2004) 
highlighted that the moral discourse presents the use of 
drugs as the responsibility of the user, blaming them for not 
having the moral force to stop their use. The results of this 
study show how these discourses lead to the disinvestment of 
professionals in the mental health services.
Van Boekel, Brouwers, van Weeghel and Garretsen 
(2013) highlighted that, among the reasons that influence 
the negative attitudes of professionals towards the use of 
drugs by psychiatric patients, there is a perception that they 
do not have the necessary tools to promote care, generating 
demotivation and impacting on the professional’s self-
esteem. For Crapanzano, Vath and Fisher (2014), training for 
psychiatry professionals should have more space to discuss 
previous beliefs, as there may be difficulties in reconciling 
the understandings they already have about drug use with 
the new perspectives presented in the training. Participant 
P7 related how specific drug training helped him change 
his view: “I confess that I had a certain prejudice regarding 
abusive use of any drug, but I had a training course in mental 
health, crack, alcohol and drugs and I have to say, to confess, 
that I have undergone a radical change”.
As previously mentioned, P7’s posture on drug use was 
first influenced by family reports of the experience with a 
family member. The training in the use of drugs made it 
possible to construct new understandings about the subject, 
changing his posture and expanding the possibilities of action. 
Despite the training in mental health, moral discourses 
influence how professionals relate to psychiatric patients 
who use drugs (Raitakari, Günther, Juhila, & Saario, 2013). 
The problematic use of drugs is perceived as a failure of 
character and responsibility of the individual, leading to a 
disinvestment of the team and lack of responsibility. The 
stigma in this area is such an important factor that there are 
educational books that approach this issue with professionals. 
The guide for reducing stigma among drug users highlights 
the need to evaluate the human dimension of drug use, 
seeking to understand the relationship that each person 
establishes with consumption, and also draws attention to the 
importance of the therapeutic alliance for treatment success 
(Ronzani et al., 2014). As treatment in mental health services 
is still very focused on the use of medications and the 
interaction of these with recreational drugs can be harmful, 
the team feels without resources to deal with these people, 
seeking referral to other services. It is interesting to note that 
when professionals expand their understanding of drug use 
beyond the moral discourse and consider it as an attempt at 
self-medication or as a confronting resource, they construct 
possibilities for negotiation and dialogue with users, seeking 
to better understand the meanings of consumption for them, 
creating care alternatives. 
Although the literature suggests the use of standardized 
instruments and toxicological tests, the analysis identified 
that the light technologies (Merhy, 2002) related to listening, 
bonding, welcoming and autonomization seem to be the 
strategies considered potent in the service to collect the 
patient’s report on drug use and to construct care strategies 
with user and professional engagement. 
It was identified that mental health training and 
work experience in the area do not seem to ensure that 
professionals feel empowered to deal with drug use issues 
among psychiatric patients. Conversely, more specific 
training related to the topic of drugs seems to help in the 
change of beliefs and postures of the professionals, helping 
them to become more involved with the case and to seek 
alternatives of care. Different forms of training have been 
proposed and studied, such as the use of the debate wheel 
technique in which the mediator uses a trigger to start the 
discussion on a given topic (Gallassi, Souza, & Silva, 2016) 
or the development of collaborative projects among different 
professionals (Matta et al., 2016). In this sense, the fact that 
the participants did not mention any joint work with experts 
in the treatment of drugs draws attention. Alternatives such 
as shared care through discussions between mental health 
service teams and specialized services in alcohol and other 
drugs can also be promising in this area, however, it is 
necessary for professionals in both services to overcome 
barriers and recognize inherent limitations to their specialty, 
seeking to jointly discuss measures to be implemented 
case-by-case (Edward, Hearity, & Felstead, 2012). Group 
therapeutic strategies carried out in mental health services 
for people who use drugs can also be effective because they 
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provide a space to talk about these issues, leading to more 
awareness and management. 
Knowing how care has been offered in mental health 
services helps to check for neuralgic points and to propose 
suggestions for overcoming them, as well as to identify the 
resources that have been used by the team, disseminating 
them as strategies to be tested by other teams. This study 
showed that light technologies are essential for the 
identification and management of drug use and that the 
moral view on consumption needs to be questioned so that 
professionals can be responsible for the care and negotiate 
strategies with those individuals under psychiatric treatment 
and who cannot or do not want to be abstinent. 
From the reports of the participants, it was noted that, 
even though there is a division between mental health 
services and specialized drug services, many people 
undergoing treatment for psychiatric disorders also use 
drugs in different consumption patterns. The construction of 
spaces of conversation about how they see this consumption 
could reduce stigmas and bring the professional closer to the 
patient, strengthening bonds and enabling the construction 
of care strategies, refining the institution’s discourses and 
enabling more coherent practices within the service.
This study described strategies used to identify and 
manage drug use among psychiatric patients, however, did not 
evaluate their effectiveness. It is suggested that future studies 
be conducted to evaluate these interventions. Another limit of 
this study was to have worked with all the interviews, without 
dividing them by professional category. Studies focusing on 
distinct professional categories may help to understand how 
the different formations influence the professional’s view 
on the use of drugs by psychiatric patients and also on the 
possibilities for the care offered. However, the analysis 
presented here presents how a typical interdisciplinary team 
of community mental health services understands this subject.
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